Objective: To analyze the efficacy of transcervical resection of submucous
myomas and to identify prognostic factors for long-term results.
Methods: Two-hundred eighty-five women were treated with transcervical rese
ction of submucous myomas without endometrial ablation. In case of incomple
te resection a repeat procedure was offered. Long-term follow-up was obtain
ed. Recurrence was defined as the need for further surgery. The relation of
several variables with the outcome was analyzed using Cox proportional haz
ard regression analysis.
Results: Seventeen cases (6%) were lost to follow-up. The median follow-up
was 46 months (range 1-104. months); for cases without recurrence median fo
llow-up was 42 months (range 16-104 months). Forty-one (14.5%) patients had
repeat surgery. An independent prognostic value of uterine size (P < .001)
and number of submucous myomas (P < .001) for recurrence was noted. Twenty
of 41 patients who had repeat surgery subsequently had a hysterectomy. Non
e of the variables investigated predicted the need for hysterectomy. The su
rgery-free percentage of 165 patients with normal sized uteri and not more
than two myomas was 94.3% (standard error +/- 1.8%) at 2 years and 90.3% (/- 3.0%) at 5 years.
Conclusion: Transcervical resection of submucous myomas is a safe and effec
tive treatment for patients with a normal sized uterus and not more than tw
o myomas. It is an acceptable alternative for selected other patients. The
need for a combined endometrial ablation is questionable. Transcervical res
ection of submucous myomas will give patients a high chance of averting fur
ther surgery and should modify the way patients are counseled. (C) 1999 by
The American College of Obstetricians and Gynecologists.